Hardware Startup Fundraising: What's Different from SaaS

Hardware startups need more capital, structured differently, across more rounds than SaaS. This guide covers the fundraising mechanics, investment instruments, non-dilutive capital access, and IP structures that define the hardware financing landscape.

Hardware Startup Fundraising: What's Different from SaaS
Loading AudioNative Player...

Table of contentsLoading the Elevenlabs Text to Speech AudioNative Player...

The Capital Reality: Hardware Burns Differently

Hardware startups don't just need more money than their SaaS counterparts — they need it structured differently, deployed faster, and sourced from multiple channels simultaneously. At equivalent milestones, capital-intensive hardware companies must raise 20–50% more equity than SaaS peers, plus roughly double that amount again in non-dilutive financing. That math compounds across every stage.

The milestone math compounds fast. A typical SaaS company moves from seed to exit across 3–4 equity rounds. Capital-intensive hardware companies can require 14 or more funding rounds — illustrated by Northvolt, which executed 8 equity and 6 debt rounds between 2017 and 2024. Series B hardware companies routinely need $30M or more just for pilot manufacturing facilities.

Margin structure makes fundraising harder. SaaS businesses average 77% gross margins; hardware margins are volume-dependent and start far lower. SaaS commands EV/Revenue multiples of 3.0x versus 1.4x for hardware, meaning every dollar raised buys less runway on paper.

Then there's the minimum order quantity (MOQ) trap. A single $40,000 component purchase — say, $8 per unit at a 5,000-unit MOQ — locks working capital in inventory that can't be liquidated quickly.

📊
Only 24% of hardware startups successfully raise a second round, and 38% of hardware startup failures trace back to inability to secure follow-on capital.

Stage Gates Investors Measure You By

Hardware investors don't care how polished your deck is if they can't locate you on the prototype progression map. The industry standard runs three phases: EVT, DVT, and PVT. Engineering Validation Test (EVT) produces the first build that combines intended form and function in production-intent materials — typically 100 to 1,000 units. Design Validation Test (DVT) follows with 300 to 2,000 units. Production Validation Test (PVT) is the last build before commercial sale, running 1,000 to 20,000 units.

Where you sit on that ladder determines which investor conversations are worth having. Seed rounds typically close around EVT or early DVT. By the time you're raising a Series A, investors expect shipped units, repeatable production processes, and a visible cost-reduction pathway.

The margin gap between hardware and software sharpens this scrutiny. SaaS businesses typically operate at 75–80% gross margins. Hardware gross margins frequently start near 30%, with investors expecting a clear trajectory toward 50% at volume. DFM failure is among the most commonly cited root causes of product cycle failures.

Non-Dilutive Capital Hardware Founders Can Access

Hardware founders can access non-dilutive funding channels that most SaaS companies are structurally ineligible for — a meaningful advantage that changes the equity math at early stages. The SBIR/STTR program is the largest single source. Phase I awards average $323,090 and Phase II awards average $2,153,927 across agencies, and multiple agencies accept hardware applications simultaneously. NSF's Phase I is $305,000 with Phase II at $1,250,000; DOE's Phase I reaches $200,000 with Phase II at $1,100,000.

One agency most founders overlook is NIST. NIST SBIR Phase I awards run up to $100,000 — and up to $400,000 for exceptional applications — with notably thin competition relative to NIH and DOD. The field is smaller because fewer founders know to apply, which improves your odds considerably. If your hardware touches metrology, standards, or advanced manufacturing, NIST deserves a serious look before you file that next equity pitch deck.

Congress has also placed a structural bet on hardware-adjacent R&D through the CHIPS and Science Act, which allocated $11 billion for semiconductor and hardware-adjacent programs. Not all of that capital flows through clean grant mechanisms, but it has seeded agency programs and procurement pipelines that founders in photonics, advanced packaging, and semiconductor subsystems can tap.

💡
Timing is the variable most founders get wrong. Non-dilutive capital should be pursued in parallel with equity raises, not as a substitute when equity conversations stall. Every grant dollar captured before a priced round reduces dilution at the moment your valuation is least established — and that asymmetry is permanent.

If you are structuring your early funding stack, the mechanics of how non-dilutive capital interacts with SAFE notes and convertible instruments matters — grant funds treated as revenue can affect post-money SAFE calculations in ways that are worth reviewing with counsel before you close either instrument.

Instruments and Deal Terms for Hardware Founders

Hardware seed rounds historically carry 20–25% dilution — measurably higher than typical SaaS norms — which means every instrument you sign at the early stages has compounding consequences. SAFE notes are common at seed, but hardware timelines create a structural hazard: when a company raises multiple SAFEs over 18–24 months of development, each note may carry a different valuation cap. At Series A, all of those instruments convert simultaneously, and the dilution arithmetic can surprise founders who didn't model the stack at the time each note was signed. That kind of cap table complexity is largely a hardware-specific problem, born from the protracted time between initial fundraising and a priced round. Before raising a second SAFE on top of an existing one, founders should run the conversion math at several Series A price scenarios — not after the term sheet arrives.

Hardware also has access to debt instruments that are structurally unavailable to most SaaS companies: you have collateralizable assets. Equipment, tooling, inventory, and manufacturing fixtures can secure financing in ways that software simply cannot. SBA 7(a) loans offer up to $5 million per loan — a meaningful ceiling for a company acquiring CNC equipment, injection molds, or PCB production capacity. An equipment financing line or SBA loan sitting alongside your equity raise can meaningfully reduce the dilution burden at a stage when every percentage point matters.

Strategic investors — large manufacturers, OEMs, or tier-one suppliers — represent a different category of risk entirely. The capital is often patient and the operational value (distribution, manufacturing relationships, component access) can be genuine. But term sheets from strategic investors frequently include provisions that purely financial investors don't ask for: rights of first refusal on acquisitions, board observer rights with information triggers, and licensing-back clauses. An M&A right-of-first-refusal embedded in a strategic investor's warrant agreement can effectively cap your exit universe to one buyer at a negotiated price — or require you to run a process that tips your hand to a competitor. These provisions are negotiable at the time of signing. They are substantially harder to unwind later.

⚖️
Hardware SAFEs, convertible notes, and strategic warrants each carry term-level risks that standard SaaS fundraising templates don't address. A full comparison of convertible notes versus SAFEs — including when each structure creates downstream cap table problems — is a topic the Promise Legal startup blog covers in depth. For hardware founders specifically, the instrument choice is inseparable from your manufacturing timeline and projected Series A window.

Finding Investors Who Understand Hardware

Pitching the wrong investor isn't just a fundraising inefficiency — it's a structural risk to your company. A generalist lead investor who has never watched a 6-month tooling delay unfold will almost certainly pressure you to compress validation timelines, skip DFM iterations, or rush to manufacturing before the product is ready. That pressure doesn't stay in the boardroom. It propagates into engineering decisions, and the product that ships reflects it.

Hardware-specialist funds exist precisely because this pattern is predictable. Lemnos, a seed-stage fund focused on engineering and manufacturing intensity, brings the kind of pattern recognition that knows the difference between a delay that signals execution risk and one that signals a team doing the work correctly. Playground Global writes initial checks of $3–15M and brings operational manufacturing support capacity — not just capital. These investors don't panic at UL certification timelines or regulatory hold periods because they've seen them before and know how to read them. Generalist VCs, however experienced in software, cannot replicate that institutional knowledge.

With early-stage hardware funding down 14% in recent periods, the instinct to maximize investor meetings makes sense — but qualification matters more than volume. Chasing a full pipeline of misaligned investors wastes time you could spend reaching the handful of funds where your deal actually fits. Before any pitch, ask the firm directly: have you held a portfolio company through a tooling delay? What did you do? The answer tells you more than any term sheet conversation will.

🔩
Hardware-focused funds to research before your seed or Series A raise: Lemnos, Playground Global, Bolt, Grishin Robotics, Fontinalis Partners, and SOSV's HAX accelerator. Each has a distinct focus area — match your category before cold-reaching.

IP strategy is not a separate workstream from fundraising — it is fundraising strategy. In hardware M&A, patent moats are a primary valuation driver: acquirers pay a measurable premium for defensible IP that competitors cannot design around. Founders who treat patents as an afterthought discover this at the worst possible moment, when a term sheet arrives with a valuation haircut or a deal dies in diligence.

The patent-versus-trade-secret decision for manufacturing processes is one of the most consequential early-stage choices a hardware founder makes. Patent disclosure enables competitors to study your claims and engineer around them; for processes that can realistically stay secret inside a manufacturing relationship, trade secret protection is often the stronger posture. That calculus depends on what you're protecting, who has access to it, and how long your competitive window needs to last — none of which has a universal answer.

Due diligence on IP surfaces surprises that kill or reprice deals far more often than founders expect. Chain of title gaps, employee IP assignment agreements that were never executed, and disputes over design patent scope are recurring issues in hardware M&A — and they are cheap to fix before a raise, expensive to explain during one. If a co-founder wrote firmware before your entity existed, or a contractor built a prototype without a proper assignment, that gap will show up in diligence.

Strategic investors add another layer of complexity. Hardware-specific term sheets frequently include manufacturing exclusivity provisions and IP licensing-back clauses that can significantly constrain how you use your own technology post-acquisition. These provisions require attorney expertise to identify and negotiate — they are easy to miss in a 40-page term sheet when you're focused on valuation and dilution.

⚖️
Hardware founders raising a seed or Series A round should conduct an IP audit before the raise — not after a term sheet lands. Assignment gaps and chain of title issues are fixable in weeks when you control the timeline; they become leverage points for investors when you don't.

Promise Legal works with hardware founders on IP strategy, term sheet review, and fundraising structure — before the raise, not during the scramble. If you're heading into a seed or Series A and want to pressure-test your IP position and deal terms, schedule a consultation with our hardware startup team.